Genomics-Guided Tool Helps Guide Immunotherapy Choices for Advanced Kidney Cancers
Summary by Medical Xpress
2 Articles
2 Articles
Genomics-guided tool helps guide immunotherapy choices for advanced kidney cancers
A study led by Roswell Park Comprehensive Cancer Center helps explain why a rare and hyper-aggressive subtype of kidney cancer is susceptible to immunotherapy—information that helped researchers create a first-of-its-kind tool to guide treatment decisions for advanced kidney cancers.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium